Update on B12 Deficiency Guidance by Lothian Health Services

 
Lothian B12 guidance update
 
Dr Sara Jenks
Consultant Chemical pathology/Metabolic Medicine
 
On behalf of B12 guideline team - Nadeen Brown (GP), Catriona
Morton (GP), Alice Klauser (Haematology), Kirsty McCance
(Biochemistry), Peter & Helen Gillet (GI), Richard Davenport,  Jon
Stone (Neuro), Charu Chopra (Immunology)
 
 
Guideline
 
Similar to current guideline but additional sections with added info re:
Neuro symptoms
Coeliac
Discontinuing treatment/switching from IM to oral
 
Background
 
Vitamin B12 is an 
enzyme cofactor - required for the development,
myelination, and function of the central nervous system; healthy red
blood cell formation; and DNA synthesis
Deficiency is not straightforward to define – markers used include
total B12 levels
, holocobalamin (‘active B12’), Urine methyl malonic
acid and homocysteine – none are perfect
 
When to test
 
Macrocytosis +/- anaemia 
or 
strong clinical suspicion with no other identifiable
cause
e.g. visual disturbance, memory loss, psychiatric abnormalities, peripheral neuropathies, oral
glossitis/ulceration, malabsorption syndromes and cytopenias
Tiredness alone is not an indication for testing
Metformin treatment alone is not an indication for testing
 
 
Pernicious anaemia
 
i
f
 
B
1
2
 
<
1
8
0
 
l
a
b
 
w
i
l
l
 
a
u
t
o
m
a
t
i
c
a
l
l
y
 
a
d
d
 
I
F
 
a
n
t
i
b
o
d
i
e
s
 
I
F
 
A
b
 
p
o
s
i
t
i
v
e
IF Abs are reasonably specific – a positive result suggests a diagnosis of
pernicious anaemia
 
I
F
 
A
b
 
n
e
g
a
t
i
v
e
30-50% of individuals with pernicious anaemia are IF Ab negative.
There is NO role for gastric parietal cell antibody testing  - poorly specific
and a negative result does not rule out pernicious anaemia.
In individuals who are IF Ab negative and fail to respond to the max oral
dose of cyanocobalamin consider a diagnosis of pernicious anaemia
 
B12 & neuro symptoms
 
-
Neurological symptoms may be the only manifestation of B12
deficiency
-
can occur with normal B12 levels (rare).
-
Symptoms include: lower limb sensory symptoms suggestive of
either a spinal cord lesion (subacute combined degeneration or
peripheral neuropathy – in particular proprioception and
vibration loss) or visual (optic neuropathy)
.
 
B12 & neuro symptoms
 
-
Sensory symptoms are common in the normal population
-
Modestly reduced B12 levels (e.g. 125 to 180pg/mL) are often “false
positives” (i.e. there is no connection between the symptoms and result)
-
People with mild or intermittent lower limb sensory symptoms, retained
ankle reflexes or normal vibration sense at the toes are unlikely to have a
B12 deficiency related neurological syndrome. Most such people,
especially if symptoms are variable and intermittent, can be managed
conservatively
-
For people with mild sensory symptoms who have been started on IM
treatment and are not responding it is unlikely that the symptoms were
due to B12 deficiency.
-
Consider alternative explanations and discontinue alt day IM treatment
after 2 weeks.  Maintenance may then be via the oral route unless there is
a specific indication for IM
 
B12 & neuro symptoms
 
-
Significant B12 neurological symptoms can take several months to
improve and may not recover completely even with replacement. Suggest
wait at least 3 months for a clinical response.
-
Seek specialist advice only if symptoms are severe, there is diagnostic
uncertainty and a neurology opinion is required to help determine the
cause.
 
Coeliac disease & B12 deficiency
 
Vitamin B12 levels should be measured at time of diagnosis of Coeliac Disease.
Low B12 levels are likely to be secondary to malabsorption and should improve
with gluten exclusion.
Intrinsic Factor should be checked as a dual diagnosis of Pernicious anaemia and
coeliac disease is possible
In adults it is prudent to give intramuscular replacement initially, but then move
to oral, or no, B12 supplementation once the anti-tTG has normalised.
A small number of patients will have ongoing poor dietary compliance, with high
Anti-tTG, and may need ongoing supplementation, some by injection.
 
Switching from IM to oral OR discontinuing
B12 treatment
 
-
Lack of evidence/guidance on which to base best practice
-
Body stores can last anything from 1 – 11 years, although the
consensus suggests 2-4 years.
-
So for individuals previously on B12 treatment it may take
years for their liver B12 stores to become depleted after
treatment cessation and the B12 deficiency may recur if the
cause has not been addressed.
 
 
 
 
-
Length of checks depends on how likely is is that the patient may have undiagnosed pernicious anaemia or
another malabsorptive state meaning that over time their B12 levels will once again become depleted.
 
-
NB: Individuals with pernicious anaemia or significant neurological symptoms with a clear response to IM
B12 treatment should usually continue on IM B12 treatment lifelong
 
Questions?
 
If felt useful to have a longer educational session on this let us know
Slide Note

Brief overview of guidelines

Ideally would have had a longer session for this

Embed
Share

Vitamin B12 deficiency is a complex condition with various manifestations, including neurological symptoms. The updated guidelines address key areas such as neuro symptoms, coeliac disease, and transitioning from intramuscular to oral treatment. Testing indications and approaches for pernicious anaemia are also discussed, emphasizing the importance of comprehensive evaluation and appropriate management strategies.

  • B12 deficiency
  • Neurological symptoms
  • Pernicious anaemia
  • Guidance update
  • Lothian Health

Uploaded on Jul 22, 2024 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. Lothian B12 guidance update Dr Sara Jenks Consultant Chemical pathology/Metabolic Medicine On behalf of B12 guideline team - Nadeen Brown (GP), Catriona Morton (GP), Alice Klauser (Haematology), Kirsty McCance (Biochemistry), Peter & Helen Gillet (GI), Richard Davenport, Jon Stone (Neuro), Charu Chopra (Immunology)

  2. Guideline B12 deficiency (nhslothian.scot) Similar to current guideline but additional sections with added info re: Neuro symptoms Coeliac Discontinuing treatment/switching from IM to oral

  3. Background Vitamin B12 is an enzyme cofactor - required for the development, myelination, and function of the central nervous system; healthy red blood cell formation; and DNA synthesis Deficiency is not straightforward to define markers used include total B12 levels, holocobalamin ( active B12 ), Urine methyl malonic acid and homocysteine none are perfect

  4. When to test Macrocytosis +/- anaemia or strong clinical suspicion with no other identifiable cause e.g. visual disturbance, memory loss, psychiatric abnormalities, peripheral neuropathies, oral glossitis/ulceration, malabsorption syndromes and cytopenias Tiredness alone is not an indication for testing Metformin treatment alone is not an indication for testing

  5. Pernicious anaemia if B12 <180 lab will automatically add IF antibodies IF Ab positive IF Abs are reasonably specific a positive result suggests a diagnosis of pernicious anaemia IF Ab negative 30-50% of individuals with pernicious anaemia are IF Ab negative. There is NO role for gastric parietal cell antibody testing - poorly specific and a negative result does not rule out pernicious anaemia. In individuals who are IF Ab negative and fail to respond to the max oral dose of cyanocobalamin consider a diagnosis of pernicious anaemia

  6. B12 & neuro symptoms - Neurological symptoms may be the only manifestation of B12 deficiency - can occur with normal B12 levels (rare). - Symptoms include: lower limb sensory symptoms suggestive of either a spinal cord lesion (subacute combined degeneration or peripheral neuropathy in particular proprioception and vibration loss) or visual (optic neuropathy).

  7. B12 & neuro symptoms - Sensory symptoms are common in the normal population - Modestly reduced B12 levels (e.g. 125 to 180pg/mL) are often false positives (i.e. there is no connection between the symptoms and result) - People with mild or intermittent lower limb sensory symptoms, retained ankle reflexes or normal vibration sense at the toes are unlikely to have a B12 deficiency related neurological syndrome. Most such people, especially if symptoms are variable and intermittent, can be managed conservatively - For people with mild sensory symptoms who have been started on IM treatment and are not responding it is unlikely that the symptoms were due to B12 deficiency. - Consider alternative explanations and discontinue alt day IM treatment after 2 weeks. Maintenance may then be via the oral route unless there is a specific indication for IM

  8. B12 & neuro symptoms - Significant B12 neurological symptoms can take several months to improve and may not recover completely even with replacement. Suggest wait at least 3 months for a clinical response. - Seek specialist advice only if symptoms are severe, there is diagnostic uncertainty and a neurology opinion is required to help determine the cause.

  9. Coeliac disease & B12 deficiency Vitamin B12 levels should be measured at time of diagnosis of Coeliac Disease. Low B12 levels are likely to be secondary to malabsorption and should improve with gluten exclusion. Intrinsic Factor should be checked as a dual diagnosis of Pernicious anaemia and coeliac disease is possible In adults it is prudent to give intramuscular replacement initially, but then move to oral, or no, B12 supplementation once the anti-tTG has normalised. A small number of patients will have ongoing poor dietary compliance, with high Anti-tTG, and may need ongoing supplementation, some by injection.

  10. Switching from IM to oral OR discontinuing B12 treatment - Lack of evidence/guidance on which to base best practice - Body stores can last anything from 1 11 years, although the consensus suggests 2-4 years. - So for individuals previously on B12 treatment it may take years for their liver B12 stores to become depleted after treatment cessation and the B12 deficiency may recur if the cause has not been addressed.

  11. Length of checks depends on how likely is is that the patient may have undiagnosed pernicious anaemia or another malabsorptive state meaning that over time their B12 levels will once again become depleted. - NB: Individuals with pernicious anaemia or significant neurological symptoms with a clear response to IM B12 treatment should usually continue on IM B12 treatment lifelong -

  12. Questions? If felt useful to have a longer educational session on this let us know

Related


More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#